Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 49 Records) |
| Query Trace: Neoplasms and CYP3A[original query] |
|---|
| Vincristine pharmacodynamics and pharmacogenetics in children with cancer: a limited-sampling, population modelling approach. Journal of paediatrics and child health 2011 Dec 47 (12): 875-82. Moore Andrew S, Norris Ross, Price Gareth, Nguyen Thu, Ni Ming, George Rani, van Breda Karin, Duley John, Charles Bruce, Pinkerton Ro |
| CYP3A variation, premenopausal estrone levels, and breast cancer risk. Journal of the National Cancer Institute 2012 May 104 (9): 657-69. Johnson Nichola, Walker Kate, Gibson Lorna J, Orr Nick, Folkerd Elizabeth, Haynes Ben, Palles Claire, Coupland Ben, Schoemaker Minouk, Jones Michael, Broderick Peter, Sawyer Elinor, Kerin Michael, Tomlinson Ian P, Zvelebil Marketa, Chilcott-Burns Sarah, Tomczyk Katarzyna, Simpson Gemma, Williamson Jill, Hillier Stephen G, Ross Gillian, Houlston Richard S, Swerdlow Anthony, Ashworth Alan, Dowsett Mitch, Peto Julian, Dos Santos Silva Isabel, Fletcher Oliv |
| Nonsteroidal anti-inflammatory drugs and other analgesic use and bladder cancer in northern New England. International journal of cancer. Journal international du cancer 2013 Jan 132 (1): 162-73. Baris Dalsu, Karagas Margaret R, Koutros Stella, Colt Joanne S, Johnson Alison, Schwenn Molly, Fischer Alexander H, Figueroa Jonine D, Berndt Sonja I, Han Summer, Beane Freeman Laura E, Lubin Jay H, Cherala Sai, Cantor Kenneth P, Jacobs Kevin, Chanock Stephen, Chatterjee Nilanjan, Rothman Nathaniel, Silverman Debra |
| CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients. Journal of clinical pharmacology 2014 Feb 54 (2): 215-24. Seng Kok-Yong, Hee Kim-Hor, Soon Gaik Hong, Sapari Nur Sabrina, Soong Richie, Goh Boon-Cher, Lee Lawrence Soon |
| CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin. Pharmacogenomics 2013 Jan 14 (2): 137-49. Elens Laure, Nieuweboer Annemieke, Clarke Stephen J, Charles Kellie A, de Graan Anne-Joy, Haufroid Vincent, Mathijssen Ron H J, van Schaik Ron H |
| Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin. Pharmacogenetics and genomics 2013 Mar 23 (3): 148-55. Elens Laure, Nieuweboer Annemieke J M, Clarke Stephen J, Charles Kellie A, de Graan Anne-Joy M, Haufroid Vincent, van Gelder Teun, Mathijssen Ron H J, van Schaik Ron H |
| Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast cancer research : BCR 2014 16 (3): R51. Johnson Nichola, Dudbridge Frank, Orr Nick, Gibson Lorna, Jones Michael E, Schoemaker Minouk J, Folkerd Elizabeth J, Haynes Ben P, Hopper John L, Southey Melissa C, Dite Gillian S, Apicella Carmel, Schmidt Marjanka K, Broeks Annegien, Van't Veer Laura J, Atsma Femke, Muir Kenneth, Lophatananon Artitaya, Fasching Peter A, Beckmann Matthias W, Ekici Arif B, Renner Stefan P, Sawyer Elinor, Tomlinson Ian, Kerin Michael, Miller Nicola, Burwinkel Barbara, Marme Frederik, Schneeweiss Andreas, Sohn Christof, Guénel Pascal, Truong Therese, Cordina Emilie, Menegaux Florence, Bojesen Stig E, Nordestgaard Børge G, Flyger Henrik, Milne Roger, Zamora M Pilar, Arias Perez Jose Ignacio, Benitez Javier, Bernstein Leslie, Anton-Culver Hoda, Ziogas Argyrios, Clarke Dur Christina, Brenner Hermann, Müller Heiko, Arndt Volker, Dieffenbach Aida Karina, Meindl Alfons, Heil Joerg, Bartram Claus R, Schmutzler Rita K, Brauch Hiltrud, Justenhoven Christina, Ko Yon-Dschun, , Nevanlinna Heli, Muranen Taru A, Aittomäki Kristiina, Blomqvist Carl, Matsuo Keitaro, Dörk Thilo, Bogdanova Natalia V, Antonenkova Natalia N, Lindblom Annika, Mannermaa Arto, Kataja Vesa, Kosma Veli-Matti, Hartikainen Jaana M, Chenevix-Trench Georgia, Beesley Jonathan, , , Wu Anna H, Van den Berg David, Tseng Chiu-Chen, Lambrechts Diether, Smeets Dominiek, Neven Patrick, Wildiers Hans, Chang-Claude Jenny, Rudolph Anja, Nickels Stefan, Flesch-Janys Dieter, Radice Paolo, Peterlongo Paolo, Bonanni Bernardo, Pensotti Valeria, Couch Fergus J, Olson Janet E, Wang Xianshu, Fredericksen Zachary, Pankratz Vernon S, Giles Graham G, Severi Gianluca, Baglietto Laura, Haiman Chris, Simard Jacques, Goldberg Mark S, Labrèche France, Dumont Martine, Soucy Penny, Teo Soo, Yip Cheng Har, Phuah Sze Yee, Cornes Belinda K, Kristensen Vessela N, Grenaker Alnæs Grethe, Børresen-Dale Anne-Lise, Zheng Wei, Winqvist Robert, Pylkäs Katri, Jukkola-Vuorinen Arja, Grip Mervi, Andrulis Irene L, Knight Julia A, Glendon Gord, Mulligan Anna Marie, Devillee Peter, Figueroa Jonine, Chanock Stephen J, Lissowska Jolanta, Sherman Mark E, Hall Per, Schoof Nils, Hooning Maartje, Hollestelle Antoinette, Oldenburg Rogier A, Tilanus-Linthorst Madeleine, Liu Jianjun, Cox Angie, Brock Ian W, Reed Malcolm W R, Cross Simon S, Blot William, Signorello Lisa B, Pharoah Paul D P, Dunning Alison M, Shah Mitul, Kang Daehee, Noh Dong-Young, Park Sue K, Choi Ji-Yeob, Hartman Mikael, Miao Hui, Lim Wei Yen, Tang Anthony, Hamann Ute, Försti Asta, Rüdiger Thomas, Ulmer Hans Ulrich, Jakubowska Anna, Lubinski Jan, Jaworska-Bieniek Katarzyna, Durda Katarzyna, Sangrajrang Suleeporn, Gaborieau Valerie, Brennan Paul, McKay James, Slager Susan, Toland Amanda E, Vachon Celine, Yannoukakos Drakoulis, Shen Chen-Yang, Yu Jyh-Cherng, Huang Chiun-Sheng, Hou Ming-Feng, González-Neira Anna, Tessier Daniel C, Vincent Daniel, Bacot Francois, Luccarini Craig, Dennis Joe, Michailidou Kyriaki, Bolla Manjeet K, Wang Jean, Easton Douglas F, García-Closas Montserrat, Dowsett Mitch, Ashworth Alan, Swerdlow Anthony J, Peto Julian, dos Santos Silva Isabel, Fletcher Oliv |
| Erlotinib in African Americans with advanced non-small cell lung cancer: a prospective randomized study with genetic and pharmacokinetic analyses. Clinical pharmacology and therapeutics 2014 Aug 96 (2): 182-91. Phelps M A, Stinchcombe T E, Blachly J S, Zhao W, Schaaf L J, Starrett S L, Wei L, Poi M, Wang D, Papp A, Aimiuwu J, Gao Y, Li J, Otterson G A, Hicks W J, Socinski M A, Villalona-Calero M |
| ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy. Cancer science 2015 Jan 106 (1): 86-93. Kim Hee-Jun, Im Seock-Ah, Keam Bhumsuk, Ham Hye Seon, Lee Kyung Hun, Kim Tae Yong, Kim Yu Jung, Oh Do-Youn, Kim Jee Hyun, Han Wonshik, Jang In-Jin, Kim Tae-You, Park In Ae, Noh Dong You |
| Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study. Pharmacogenetics and genomics 2014 Apr 24 (4): 185-94. Barratt Daniel T, Bandak Benedikte, Klepstad Pål, Dale Ola, Kaasa Stein, Christrup Lona L, Tuke Jonathan, Somogyi Andrew |
| Association of CYP3A variants with kidney transplant outcomes. Renal failure 2015 May 37 (4): 562-6. Traynor Carol, Conlon Peter, Phelan Paul J, O'Kelly Patrick, Elens Laure, McCormack Mark, Cavalleri Gianpiero, Comber Harry, van Schaik R H N, Conlon Peter |
| Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer. Cancer research 2016 Mar 76 (6): 1485-93. Johnson Nichola, De Ieso Paolo, Migliorini Gabriele, Orr Nick, Broderick Peter, Catovsky Daniel, Matakidou Athena, Eisen Timothy, Goldsmith Christy, Dudbridge Frank, Peto Julian, Dos-Santos-Silva Isabel, Ashworth Alan, Ross Gillian, Houlston Richard S, Fletcher Oliv |
| Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism. European journal of clinical pharmacology 2017 8 73 (12): 1589-1598. Sanchez Spitman A B, Moes D J A R, Gelderblom H, Dezentje V O, Swen J J, Guchelaar H |
| Ancestry-Adjusted Vitamin D Metabolite Concentrations in Association With Cytochrome P450 3A Polymorphisms. American journal of epidemiology 2018 04 187 (4): 754-766. Wilson Robin Taylor, Masters Loren D, Barnholtz-Sloan Jill S, Salzberg Anna C, Hartman Terryl |
| Analgesic Plasma Concentrations of Oxycodone After Surgery for Breast Cancer-Which Factors Matter? Clinical pharmacology and therapeutics 2018 04 103 (4): 653-662. Cajanus Kristiina, Neuvonen Mikko, Koskela Outi, Kaunisto Mari A, Neuvonen Pertti J, Niemi Mikko, Kalso Ei |
| Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes. Anticancer research 2017 05 37 (5): 2633-2639. Angelini Silvia, Botticelli Andrea, Onesti Concetta Elisa, Giusti Raffaele, Sini Valentina, Durante Valeria, Strigari Lidia, Gentile Giovanna, Cerbelli Bruna, Pellegrini Patrizia, Sgroi Valentina, Occhipinti Mario, DI Pietro Francesca Romana, Rossi Alessandro, Simmaco Maurizio, Mazzuca Federica, Marchetti Pao |
| The influence of CYP3A5*3 and BCRPC421A genetic polymorphisms on the pharmacokinetics of felodipine in healthy Chinese volunteers. Journal of clinical pharmacy and therapeutics 2017 Feb . Xiang Q, Li C, Zhao X, Cui Y |
| Effect of multiple-dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin. British journal of clinical pharmacology 2018 Sep . Harvey R Donald, Aransay Noemi Reguart, Isambert Nicolas, Lee Jong-Seok, Arkenau Tobias, Vansteenkiste Johan, Dickinson Paul A, Bui Khanh, Weilert Doris, So Karen, Thomas Karen, Vishwanathan Karthi |
| Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care. Journal of thrombosis and thrombolysis 2019 Sep . Gulilat Markus, Keller Denise, Linton Bradley, Pananos A Demetri, Lizotte Daniel, Dresser George K, Alfonsi Jeffrey, Tirona Rommel G, Kim Richard B, Schwarz Ute |
| Optimization of Individual Pharmacotherapy Based on Multiple Evaluations of Patient Data. Biological & pharmaceutical bulletin 2019 2 42 (2): 149-157. Naito Takafu |
| CYP3A gene variability and cancer cells response to the treatment. General physiology and biophysics 2021 3 40 (1): 49-59. Šemeláková Martina, Malini?ová Lenka, Macejová Mária, Pristaš Pet |
| Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir. The pharmacogenomics journal 2021 3 21 (3): 336-345. van Eijk Maarten, Pluim Dick, Dorlo Thomas P C, Marchetti Serena, Huitema Alwin D R, Beijnen Jos |
| Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms. European journal of drug metabolism and pharmacokinetics 2021 2 46 (2): 317-324. Yokokawa Akitomo, Kaneko Shun, Endo Sayuri, Minowa Yuki, Ayukawa Hideaki, Hirano Ryohei, Nagashima Fumio, Naruge Daisuke, Okano Naohiro, Kobayashi Takaaki, Kawai Kirio, Furuse Junji, Furuta Takashi, Shibasaki Hiro |
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
British journal of cancer 2021 Jan . Johnson Nichola, Maguire Sarah, Morra Anna, Kapoor Pooja Middha, Tomczyk Katarzyna, Jones Michael E, Schoemaker Minouk J, Gilham Clare, Bolla Manjeet K, Wang Qin, Dennis Joe, Ahearn Thomas U, Andrulis Irene L, Anton-Culver Hoda, Antonenkova Natalia N, Arndt Volker, Aronson Kristan J, Augustinsson Annelie, Baynes Caroline, Freeman Laura E Beane, Beckmann Matthias W, Benitez Javier, Bermisheva Marina, Blomqvist Carl, Boeckx Bram, Bogdanova Natalia V, Bojesen Stig E, Brauch Hiltrud, Brenner Hermann, Burwinkel Barbara, Campa Daniele, Canzian Federico, Castelao Jose E, Chanock Stephen J, Chenevix-Trench Georgia, Clarke Christine L, , Conroy Don M, Couch Fergus J, Cox Angela, Cross Simon S, Czene Kamila, Dörk Thilo, Eliassen A Heather, Engel Christoph, Evans D Gareth, Fasching Peter A, Figueroa Jonine, Floris Giuseppe, Flyger Henrik, Gago-Dominguez Manuela, Gapstur Susan M, García-Closas Montserrat, Gaudet Mia M, Giles Graham G, Goldberg Mark S, González-Neira Anna, , Guénel Pascal, Hahnen Eric, Haiman Christopher A, Håkansson Niclas, Hall Per, Hamann Ute, Harrington Patricia A, Hart Steven N, Hooning Maartje J, Hopper John L, Howell Anthony, Hunter David J, , , Jager Agnes, Jakubowska Anna, John Esther M, Kaaks Rudolf, Keeman Renske, Khusnutdinova Elza, Kitahara Cari M, Kosma Veli-Matti, Koutros Stella, Kraft Peter, Kristensen Vessela N, Kurian Allison W, Lambrechts Diether, Le Marchand Loic, Linet Martha, Lubi?ski Jan, Mannermaa Arto, Manoukian Siranoush, Margolin Sara, Martens John W M, Mavroudis Dimitrios, Mayes Rebecca, Meindl Alfons, Milne Roger L, Neuhausen Susan L, Nevanlinna Heli, Newman William G, Nielsen Sune F, Nordestgaard Børge G, Obi Nadia, Olshan Andrew F, Olson Janet E, Olsson Håkan, Orban Ester, Park-Simon Tjoung-Won, Peterlongo Paolo, Plaseska-Karanfilska Dijana, Pylkäs Katri, Rennert Gad, Rennert Hedy S, Ruddy Kathryn J, Saloustros Emmanouil, Sandler Dale P, Sawyer Elinor J, Schmutzler Rita K, Scott Christopher, Shu Xiao-Ou, Simard Jacques, Smichkoska Snezhana, Sohn Christof, Southey Melissa C, Spinelli John J, Stone Jennifer, Tamimi Rulla M, Taylor Jack A, Tollenaar Rob A E M, Tomlinson Ian, Troester Melissa A, Truong Thérèse, Vachon Celine M, van Veen Elke M, Wang Sophia S, Weinberg Clarice R, Wendt Camilla, Wildiers Hans, Winqvist Robert, Wolk Alicja, Zheng Wei, Ziogas Argyrios, Dunning Alison M, Pharoah Paul D P, Easton Douglas F, Howie A Forbes, Peto Julian, Dos-Santos-Silva Isabel, Swerdlow Anthony J, Chang-Claude Jenny, Schmidt Marjanka K, Orr Nick, Fletcher Oliv |
| Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark. Breast cancer research and treatment 2022 Apr . Hjorth Cathrine F, Damkier Per, Stage Tore B, Feddersen Søren, Hamilton-Dutoit Stephen, Rørth Mikael, Ejlertsen Bent, Lash Timothy L, Ahern Thomas P, Sørensen Henrik T, Cronin-Fenton Deird |
| Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers. JCO precision oncology 2022 2 6 e2100312. Shugg Tyler, Ly Reynold C, Rowe Elizabeth J, Philips Santosh, Hyder Mustafa A, Radovich Milan, Rosenman Marc B, Pratt Victoria M, Callaghan John T, Desta Zeruesenay, Schneider Bryan P, Skaar Todd |
| Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant. European journal of clinical pharmacology 2022 1 78 (4): 613-621. Hibino Hideyuki, Sakiyama Naomi, Makino Yoshinori, Makihara-Ando Reiko, Horinouchi Hidehito, Fujiwara Yutaka, Kanda Shintaro, Goto Yasushi, Yoshida Tatsuya, Okuma Yusuke, Shinno Yuki, Murakami Shuji, Hashimoto Hironobu, Akiyoshi Takeshi, Imaoka Ayuko, Ohe Yuichiro, Yamaguchi Masakazu, Ohtani Hisaka |
| Is higher docetaxel clearance in prostate cancer patients explained by higher CYP3A: An in vivo phenotyping study with midazolam. Journal of clinical pharmacology 2023 10 . Lisa T van der Heijden, Claire A Ribbers, M A C Vermunt, D Pluim, M Acda, M Tibben, H Rosing, J A J Douma, K Naipal, A M Bergman, J H Beijnen, A D R Huitema, F L Opd |
| Impact of Posaconazole and Diltiazem on Pharmacokinetics of Encorafenib, a BRAF V600 Kinase Inhibitor for Melanoma and Colorectal Cancer with BRAF Mutations. Clinical and translational science 2023 10 . Erik Hahn, Renae Chavira, Lance Wollenberg, Weiwei Tan, Micaela B Red |
| Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions. Frontiers in pharmacology 2024 9 15 1420174. Elena Peruzzi, Bianca Posocco, Lorenzo Gerratana, Margherita Nuti, Marco Orleni, Sara Gagno, Elena De Mattia, Fabio Puglisi, Erika Cecchin, Giuseppe Toffoli, Rossana Ronca |
- Page last reviewed:Feb 1, 2024
- Content source: